rs779475596
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 1P and 11B. PP2BP4_ModerateBP6BS1BS2
The ENST00000375135.4(FGD1):c.62A>T(p.Asn21Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000146 in 1,030,797 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000375135.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGD1 | NM_004463.3 | c.62A>T | p.Asn21Ile | missense_variant | 1/18 | ENST00000375135.4 | NP_004454.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGD1 | ENST00000375135.4 | c.62A>T | p.Asn21Ile | missense_variant | 1/18 | 1 | NM_004463.3 | ENSP00000364277 | P1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.000170 AC: 14AN: 82351Hom.: 0 AF XY: 0.000118 AC XY: 3AN XY: 25465
GnomAD4 exome AF: 0.0000146 AC: 15AN: 1030797Hom.: 0 Cov.: 31 AF XY: 0.00000904 AC XY: 3AN XY: 331811
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 04, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2018 | The p.N21I variant (also known as c.62A>T), located in coding exon 1 of the FGD1 gene, results from an A to T substitution at nucleotide position 62. The asparagine at codon 21 is replaced by isoleucine, an amino acid with dissimilar properties. Based on data from gnomAD, the T allele has an overall frequency of approximately 0.018% (14/78876) total alleles studied. The highest observed frequency was 0.083% (14/16757) of Latino alleles, including 3 hemizygotes. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at